Smithfield Trust Co - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Smithfield Trust Co ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$34
-2.9%
2,2140.0%0.00%0.0%
Q2 2023$35
-5.4%
2,2140.0%0.00%0.0%
Q1 2023$37
+8.8%
2,2140.0%0.00%0.0%
Q4 2022$34
-99.9%
2,2140.0%0.00%0.0%
Q3 2022$29,000
-9.4%
2,2140.0%0.00%0.0%
Q2 2022$32,0000.0%2,2140.0%0.00%0.0%
Q1 2022$32,000
+6.7%
2,2140.0%0.00%0.0%
Q4 2021$30,000
-16.7%
2,2140.0%0.00%0.0%
Q3 2021$36,000
-2.7%
2,2140.0%0.00%0.0%
Q2 2021$37,000
-7.5%
2,2140.0%0.00%
-33.3%
Q1 2021$40,0000.0%2,2140.0%0.00%0.0%
Q4 2020$40,000
+2.6%
2,2140.0%0.00%0.0%
Q3 2020$39,000
-2.5%
2,2140.0%0.00%
-25.0%
Q2 2020$40,000
+17.6%
2,2140.0%0.00%0.0%
Q1 2020$34,000
-40.4%
2,214
-23.2%
0.00%
-20.0%
Q4 2019$57,000
-3.4%
2,883
-14.9%
0.01%
-16.7%
Q3 2019$59,000
-21.3%
3,386
-19.9%
0.01%
-25.0%
Q2 2019$75,000
-1.3%
4,226
+13.5%
0.01%0.0%
Q1 2019$76,0003,7230.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders